Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons11Doctors Linden and Kron disclose that they have a financial relationship with Adenosine Therapeutics LLC.
- 1 September 2002
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 74 (3) , 846-850
- https://doi.org/10.1016/s0003-4975(02)03793-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cordThe Annals of Thoracic Surgery, 2001
- An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusionJournal of Vascular Surgery, 2001
- Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashionSurgery, 2001
- The Role and Regulation of Adenosine in the Central Nervous SystemAnnual Review of Neuroscience, 2001
- Design, Synthesis, and Evaluation of Novel A2A Adenosine Receptor AgonistsJournal of Medicinal Chemistry, 2001
- A2Aadenosine receptor-mediated inhibition of renal injury and neutrophil adhesionAmerican Journal of Physiology-Renal Physiology, 2000
- Stimulation of Expression for the Adenosine A2A Receptor Gene by Hypoxia in PC12 CellsJournal of Biological Chemistry, 1999
- Spinal cord protection during aortic cross-clamping using retrograde venous perfusionThe Annals of Thoracic Surgery, 1999
- Adenosine reduces ischemia/reperfuion-induced liver injury by inhibiting leukocyte activationFolia Pharmacologica Japonica, 1999
- Inhibition of Voltage‐Sensitive Calcium Channels by the A2A Adenosine Receptor in PC12 cellsJournal of Neurochemistry, 1998